Skip to main content
. 2019 Jul 17;17(4):1038–1043. doi: 10.5114/aoms.2019.86622

Figure 1.

Figure 1

Over-expression of miR-130b is negatively correlated with doxorubicin sensitivity of BUC. A – The expression of miR-130b in doxorubicin-insensitive BUC patients was up-regulated compared with doxorubicin-sensitive BUC patients. *p < 0.05 vs. sensitive group. B – The expression of miR-130b in J82 and T24 cells was higher than that in HCV29 cells. *p < 0.05 vs. HCV29 cells. C – The IC50 of doxorubicin in J82/Dox and T24/Dox cells was higher than that in J82 and T24 cells. *p < 0.05 vs. J82 cells, #p < 0.05 vs. T24 cells. D – The miR-130b expression in J82/Dox and T24/Dox cells increased compared with J82 and T24 cells. *p < 0.05 vs. J82 cells, #p < 0.05 vs. T24 cells